Genetic aspects of amyloidosis.
Jacobson
D R
DR
Medical Service, New York Veterans Affairs Medical Center, New York.
Buxbaum
J N
JN
D000328:Adult; D000544:Alzheimer Disease / Q000235:genetics / Q000378:metabolism; D000686:Amyloidosis / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy / Q000208:ethnology / Q000235:genetics* / Q000378:metabolism; D000818:Animals; D009202:Cardiomyopathies / Q000209:etiology; D016657:Cerebral Amyloid Angiopathy; D003078:Colchicine / Q000627:therapeutic use; D007562:Creutzfeldt-Jakob Syndrome / Q000235:genetics; D055316:Cystatin C; D015891:Cystatins / Q000096:biosynthesis; D004314:Down Syndrome / Q000235:genetics / Q000378:metabolism; D010505:Familial Mediterranean Fever / Q000175:diagnosis / Q000235:genetics / Q000378:metabolism; D016098:Gerstmann-Straussler-Scheinker Disease / Q000235:genetics; D006801:Humans; D008875:Middle Aged; D009154:Mutation; D009422:Nervous System Diseases / Q000175:diagnosis / Q000235:genetics*; D011110:Polymorphism, Genetic; D011228:Prealbumin / Q000378:metabolism; D012608:Scrapie / Q000235:genetics; D000685:Serum Amyloid A Protein / Q000096:biosynthesis
C525030:CST3 protein, human; D055316:Cystatin C; D015891:Cystatins; D011228:Prealbumin; D000685:Serum Amyloid A Protein; D003078:Colchicine